News & Events about Merck Co Inc.
Globe Newswire
10 months ago
Essential Pharma appoints Lee Morley as Non-Executive Director to the Board Zug, Switzerland & Egham, UK 21 June 2023 Essential Pharma, an international specialty pharma group focused on ensuring that patients have sustainable access to low volume, clinically well-established pharmaceutical products...
Ticker Report
10 months ago
Builder Investment Group Inc. ADV bought a new stake in Merck Co., Inc. (NYSE:MRK Get Rating) in the fourth quarter, HoldingsChannel reports. The firm bought 7,743 shares of the companys stock, valued at approximately $859,000. A number of other institutional investors and hedge...
Ticker Report
10 months ago
ST Germain D J Co. Inc. lifted its stake in Merck Co., Inc. (NYSE:MRK Get Rating) by 39.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities Exchange Commission. The institutional investor owned 52,516 shares of the company&#...
NORTHAMPTON, MA / ACCESSWIRE / June 16, 2023 / Merck & Co., Inc.In underserved and under-resourced communities across the globe, from the U.S. to Rwanda, our company is helping patients at risk for and living with cancer access the care they need to stay well and lead fulfilling lives.We...
Business Wire
10 months ago
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the Phase 3 KEYNOTE-811 trial investigating KEYTRUDA, Mercks anti-PD-1 therapy, in combination with trastuzumab and chemotherapy met one of its dual primary endpoints of progression-free survival (PFS) for...